For research use only. Not for therapeutic Use.
Suplatast tosylate(Cat No.:A001050), is a pharmaceutical compound used primarily in the treatment of allergic diseases, particularly bronchial asthma and allergic rhinitis. It belongs to the class of immunomodulatory agents. Suplatast tosylate works by modulating the immune response, specifically by inhibiting the release of certain inflammatory mediators, including leukotrienes and cytokines. This mechanism of action helps alleviate allergic symptoms and improve respiratory function in individuals with asthma and allergies.
Catalog Number | A001050 |
CAS Number | 94055-76-2 |
Synonyms | IPD-1151T |
Molecular Formula | C₁₆H₂₆NO₄S.C₇H₇O₃S |
Purity | ≥95% |
Target | Interleukin Related |
Storage | Room Temperature |
IUPAC Name | [3-[4-(3-ethoxy-2-hydroxypropoxy)anilino]-3-oxopropyl]-dimethylsulfanium;4-methylbenzenesulfonate |
InChI | InChI=1S/C16H25NO4S.C7H8O3S/c1-4-20-11-14(18)12-21-15-7-5-13(6-8-15)17-16(19)9-10-22(2)3;1-6-2-4-7(5-3-6)11(8,9)10/h5-8,14,18H,4,9-12H2,1-3H3;2-5H,1H3,(H,8,9,10) |
InChIKey | RYVJQEZJUFRANT-UHFFFAOYSA-N |
SMILES | CCOCC(COC1=CC=C(C=C1)NC(=O)CC[S+](C)C)O.CC1=CC=C(C=C1)S(=O)(=O)[O-] |